Taylor McElroy

Researcher

UAMS

faculty

13 h-index 37 pubs 468 cited

Research Areas

Dementia and Cognitive Impairment Research Neuroscience and Neuropharmacology Research Cancer Treatment and Pharmacology Gut microbiota and health Mitochondrial Function and Pathology Health disparities and outcomes Diet and metabolism studies

Links

Lab Website Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Taylor H. McElroy's research investigates the physiological and cognitive impacts of various medical treatments and environmental exposures. Their work has explored the effects of chemotherapy drugs, such as docetaxel, doxorubicin, and cyclophosphamide, on cognitive function and the gut microbiome. Additionally, McElroy has studied the neuroprotective potential of compounds like piperlongumine in mitigating chemotherapy-induced cognitive impairment. Other research areas include the role of mitochondria in neuronal recovery after injury and the cognitive performance of mice exposed to simulated galactic cosmic rays. McElroy's publications also address sex differences in frailty among older adults and iron homeostasis, balancing nutritional needs with health risks in aging populations. With an h-index of 13 and 461 citations across 37 publications, McElroy collaborates with several researchers at the University of Arkansas for Medical Sciences, including Pilar Simmons, Taurean Brown, Fabio Ntagwabira, and Chase Swinton.

Metrics

  • h-index: 13
  • Publications: 37
  • Citations: 468

Selected Publications

  • Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026) DOI
  • The adverse effects of chemotherapy on bone mass are not prevented by senolytics (2025) DOI
  • Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior (2023) DOI
  • Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment (2022) DOI
  • Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021) DOI
  • Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021) DOI
  • Effects of 16O charged-particle irradiation on cognition, hippocampal morphology and mutagenesis in female mice (2021) DOI
  • Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide (2021) DOI

Collaboration Network

79 Collaborators 23 Institutions 2 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Pilar Simmons University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research Neuroscience and Neuropharmacology Research Cancer Treatment and Pharmacology
Good match 5 shared topics
Antiño R. Allen University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Cancer Treatment and Pharmacology Mitochondrial Function and Pathology
Good match 4 shared topics
Sarah C. Sullivan University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Mitochondrial Function and Pathology Diet and metabolism studies
Good match 3 shared topics
Sudeepa Bhattacharyya Arkansas State University
Neuroscience and Neuropharmacology Research Gut microbiota and health Health disparities and outcomes
Good match 4 shared topics
Fabio Ntagwabira University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research Neuroscience and Neuropharmacology Research Cancer Treatment and Pharmacology
Good match 3 shared topics
Rosalinda Medrano University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research Neuroscience and Neuropharmacology Research Health disparities and outcomes
Good match 4 shared topics